Thermo Fisher Scientific Inc
Change company Symbol lookup
Select an option...
TMO Thermo Fisher Scientific Inc
EXD Eaton Vance Tax-Managed Buy-Write Strategy Fund
ADVM Adverum Biotechnologies Inc
JRO Nuveen Floating Rate Income Opportunity Fund
SND Smart Sand Inc
EMR Emerson Electric Co
ZM Zoom Video Communications Inc
CYCN Cyclerion Therapeutics Inc
FRCGF Faircourt Gold Income Corp
BAC-O Bank of America Corp
Go

Health Care : Life Sciences Tools & Services | Large Cap Blend
Company profile

Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. It offers its products and services through various brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines. Analytical Instruments segment provides a broad offering of instruments, consumables, software and services that are used for a range of applications in the laboratory. Specialty Diagnostics segment offers a wide range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Services segment offers products and solutions needed for the laboratory.

Price
Delayed
$570.73
Day's Change
2.98 (0.52%)
Bid
--
Ask
--
B/A Size
--
Day's High
575.61
Day's Low
565.12
Volume
(Light)

Today's volume of 782,609 shares is on pace to be much lighter than TMO's 10-day average volume of 2,027,725 shares.

782,609

Display:

Providers:

UpdateCancel
6 providers
January 10, 2022
New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024

USA News Group - Nearly 10% of the estimated ~1.9 million new cancer cases in the USA will be diagnosed as leukemia, lymphoma and myeloma. According to analysts at Markets and Markets, the leukemia therapeutics market is projected to reach US$17.1...(PR Newswire)

January 05, 2022
Thermo Fisher Scientific Completes Acquisition of PeproTech, a Leader in Recombinant Proteins

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and PeproTech, Inc., a leading developer and manufacturer of recombinant proteins, today announced that Thermo Fisher completed its acquisition of PeproTech on December...(PR Newswire)

January 04, 2022
Thermo Fisher Scientific to Present at the 40th Annual J.P. Morgan Healthcare Conference

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday...(PR Newswire)

January 03, 2022
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, February 2, 2022

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2021 before the market opens on Wednesday, February 2, 2022, and will hold a...(PR Newswire)

December 30, 2021
Thermo Fisher Scientific to Present at the 2022 Goldman Healthcare CEOs Unscripted Conference

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 2022 Goldman Healthcare CEOs Unscripted Conference on...(PR Newswire)

December 08, 2021
Thermo Fisher Scientific Completes Acquisition of PPD, Inc.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. (Nasdaq: PPD), a leading global provider of clinical research services to the biopharma and biotech...(PR Newswire)

November 29, 2021
Thermo Fisher Scientific Confirms Detection of SARS-CoV-2 in Samples Containing the Omicron Variant with its TaqPath COVID-19 Tests

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today confirmed that its polymerase chain reaction (PCR) TaqPath COVID-19 Combo Kit*, and TaqPath COVID-19 CE-IVD RT-PCR Kit*, which test for the presence of SARS-CoV-2...(PR Newswire)

Thermo Fisher Scientific Confirms Detection of SARS-CoV-2 in Samples Containing the Omicron Variant with its TaqPath COVID-19 Tests

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today confirmed that its polymerase chain reaction (PCR) TaqPath COVID-19 Combo Kit*, and TaqPath COVID-19 CE-IVD RT-PCR Kit*, which test for the presence of SARS-CoV-2...(PR Newswire)

November 18, 2021
Thermo Fisher Scientific Announces Redemption of Senior Notes

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it is giving notice of its intention to redeem the following Senior Notes (the "Redemption"), representing an aggregate total principal amount of...(PR Newswire)

November 09, 2021
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes

Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") announced today that it has priced an offering of EUR 2.8 billion aggregate principal amount (the "Offering") of the following euro-denominated notes, which will be issued by Thermo Fisher...(PR Newswire)

November 05, 2021
Thermo Fisher Scientific Declares Quarterly Dividend

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.26 per common share, payable on January 14, 2022, to shareholders of record as...(PR Newswire)

November 01, 2021
Thermo Fisher Scientific Launches New Mass Spectrometry and Chromatography Solutions at ASMS 2021

ASMS 2021 -Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is empowering scientists to drive groundbreaking discoveries with the introduction of new-generation mass spectrometry instruments, workflows and software...(PR Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.